Your browser doesn't support javascript.
loading
Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment.
Campo, Paloma; Soto Campos, Gregorio; Moreira, Ana; Quirce, Santiago; Padilla-Galo, Alicia; Martínez-Moragón, Eva; Mardones, Aizea; Dávila, Ignacio.
Affiliation
  • Campo P; Allergy Unit, IBIMA-Regional University Hospital of Málaga, ARADyAL, Málaga, Spain.
  • Soto Campos G; Pneumology and Allergy Unit, University Hospital of Jerez, Cádiz, Spain.
  • Moreira A; Novartis Farmacéutica, Barcelona, Spain.
  • Quirce S; Department of Allergy, La Paz Hospital Institute for Health Research (IdiPAZ), Centro de investigación en red de enfermedades respiratorias (CIBERES), Madrid, Spain.
  • Padilla-Galo A; Pneumology Unit, Costa del Sol Hospital, Marbella, Málaga, Spain.
  • Martínez-Moragón E; Pneumology Service, University Hospital Doctor Peset, Valencia, Spain.
  • Mardones A; Pneumology Service, University Hospital Basurto, Bilbao, Spain.
  • Dávila I; Allergy Service, University Hospital of Salamanca and Institute for Biomedical Research of Salamanca (IBSAL), Biomedical and Diagnosis Science Department, Salamanca University School of Medicine, Salamanca, Spain.
Allergy ; 76(6): 1868-1872, 2021 06.
Article in En | MEDLINE | ID: mdl-33220106
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents Limits: Humans Language: En Journal: Allergy Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents Limits: Humans Language: En Journal: Allergy Year: 2021 Document type: Article Affiliation country: Country of publication: